Empagliflozin plus olanzapine to reduce metabolic side effects
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests whether adding empagliflozin to standard olanzapine treatment can improve metabolic problems (like blood sugar and cholesterol changes) that can happen with olanzapine in people with schizophrenia. If you qualify, you would be closely monitored for benefits and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old and have schizophrenia
- Currently take olanzapine (the main schizophrenia medicine)
- Need to be willing to add empagliflozin as part of the study (if randomized)
- Have no other inflammatory or major related conditions that would make participation unsafe
- Follow study visits and monitoring as required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if empagliflozin, a diabetes medicine, can improve weight and metabolism in people with HIV who take dolutegravir and have a high body mass index (BMI). It may help reduce weight gain linked to HIV treatment.
This trial tests whether dapagliflozin, a diabetes medication, can help treat major depression. It is for adults who have been depressed for at least 2 months and score high on a depression scale.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This study tests whether adding empagliflozin, a medication that helps control blood sugar, to your current bipolar depression treatment can improve depressive symptoms. It may help if you have insulin resistance, a condition where your body doesn't use insulin well.
This study tests a new combination pill (olanzapine and samidorphan) for adults with schizophrenia. It aims to see if the combination helps control symptoms while potentially reducing weight gain, which is a common side effect of olanzapine.
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
Hear when a new Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.